The Motley Fool Discussion Boards

Previous Page

Industry Discussions / Biotechnology


Subject:  Re: Is gene therapy uninvestable? Date:  10/10/2021  8:19 PM
Author:  TMFfuma102 Number:  25643 of 25647


im trying to find a gene therapy company to be excited about now. I'm struggling! I cant even find a good picks & shovel play!

the rare disease gene therapy field has shown that it has poor uptake, poor reimbursement, and overall not great investability.

Regenx (failed recently)

Im sure there are more. I was hoping something like Spark Therapeutics would be able to make an AAV platform for a series of rare genetic eye diseases, but that has never really sprung to fruition. and the GT market is so fragmented, its tough to see winners. This is looking *alot* like 2001 with the human genome biotech explosion (and to a lesser extent the RNAi hot streak). Plenty of opportunity and rosy lenses, but a rather full graveyard at the end of the day. ugh.
Copyright 1996-2022 trademark and the "Fool" logo is a trademark of The Motley Fool, Inc. Contact Us